Febuxostat
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1613 publications
Targeted degradation of xanthine oxidase via PROTAC technology for the treatment of hyperuricaemia.
Journal: Journal of materials chemistry. B
Published: April 14, 2026
DMARDs and gout therapy in patients with chronic arthritis and end-stage renal disease: a descriptive guide.
Journal: Acta clinica Belgica
Published: April 05, 2026
Allopurinol and Febuxostat Hypersensitivity in a Patient with Young Onset Gout: A Case Report.
Journal: Acta medica Philippina
Published: March 18, 2026
Response to the Comment on "Cardiovascular outcomes of febuxostat and allopurinol: A long-term Taiwanese nationwide cohort study".
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: March 08, 2026
Clinical and Comorbidity Profile of Clinically Diagnosed Gout in Two Tertiary Hospitals in Dubai, United Arab Emirates: A Retrospective Observational Study.
Journal: Cureus
Published: March 06, 2026
Febuxostat and cardiovascular outcomes: Methodological considerations and future directions.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: March 04, 2026
Molecular Mechanisms and Clinical Evidence Supporting the Four Pillars of Therapy in Diabetic Kidney Disease: Emerging Therapeutic Perspectives.
Journal: International journal of molecular sciences
Published: February 13, 2026
Clinical Impact of Febuxostat in HFpEF Versus HFrEF: Insights from a Prospective Cohort.
Journal: Balkan medical journal
Published: January 21, 2026
Chronic Tophaceous Gout Presenting With Severe Polyarticular Erosive Disease: A Case Report.
Journal: Cureus
Published: January 12, 2026
A cohort study on treatment of intermission period of gout with Quzhuo Tongbi formula ()combined with febuxostat
Journal: Zhongguo gu shang = China journal of orthopaedics and traumatology
Published: January 08, 2026
Last Updated: 04/28/2026